NSAID gastropathy

From Aaushi
Jump to navigation Jump to search

Etiology

* controversial

Epidemiology

Pathology

Clinical manifestations

* 20% of patients taking NSAIDs long-term will have endoscopic evidence of gastric or duodenal ulceration

Management

* one study found famotidine effective in prevention of both duodenal & gastric ulcers in patients on long-term NSAID therapy

More general terms

Additional terms

References

  1. 1.0 1.1 1.2 1.3 Medical Knowledge Self Assessment Program (MKSAP) 11, 15, 16, 17. American College of Physicians, Philadelphia 1998, 2009, 2012, 2015
  2. 2.0 2.1 2.2 UCLA Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 12-15, 2001
  3. 3.0 3.1 Scheiman JM et al, Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors Am J Gastroenterol 2006; 1-1:701 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16494585
  4. 4.0 4.1 Luo J-C et al. Randomised clinical trial: Rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer. Aliment Pharmacol Ther 2011 Sep; 34:519 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21726257
  5. 5.0 5.1 5.2 Lanza FL, Chan FK, Quigley EM; Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009 Mar;104(3):728-38 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19240698